Cargando…

Protective Effect of Delta-Like 1 Homolog Against Muscular Atrophy in a Mouse Model

BACKGROUND: Muscle atrophy is caused by an imbalance between muscle growth and wasting. Delta-like 1 homolog (DLK1), a protein that modulates adipogenesis and muscle development, is a crucial regulator of myogenic programming. Thus, we investigated the effect of exogenous DLK1 on muscular atrophy. M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Ji Young, Lee, Minyoung, Lee, Dong-Hee, Lee, Yong-ho, Lee, Byung-Wan, Kang, Eun Seok, Cha, Bong-Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Endocrine Society 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449104/ https://www.ncbi.nlm.nih.gov/pubmed/36065648 http://dx.doi.org/10.3803/EnM.2022.1446

Ejemplares similares

Renal Tubular Damage Marker, Urinary N-acetyl-β-D-Glucosaminidase, as a Predictive Marker of Hepatic Fibrosis in Type 2 Diabetes Mellitus
por: Kim, Hae Kyung, et al.
Publicado: (2022)

Uric Acid Variability as a Predictive Marker of Newly Developed Cardiovascular Events in Type 2 Diabetes
por: Kim, Hae Kyung, et al.
Publicado: (2021)

Dipeptidyl peptidase-4 inhibitor protects against non-alcoholic steatohepatitis in mice by targeting TRAIL receptor-mediated lipoapoptosis via modulating hepatic dipeptidyl peptidase-4 expression
por: Lee, Minyoung, et al.
Publicado: (2020)

Sodium Glucose Cotransporter-2 Inhibitors as an Add-on Therapy to Metformin Plus Dipeptidyl Peptidase-4 Inhibitor in Patients with Type 2 Diabetes
por: Bae, Jaehyun, et al.
Publicado: (2022)

Effect of Switching from Linagliptin to Teneligliptin Dipeptidyl Peptidase-4 Inhibitors in Older Patients with Type 2 Diabetes Mellitus
por: Han, Eugene, et al.
Publicado: (2020)

Tolerability and Effectiveness of Switching to Dulaglutide in Patients With Type 2 Diabetes Inadequately Controlled With Insulin Therapy
por: Kim, Youngsook, et al.
Publicado: (2022)

The effects of the voglibose on non-alcoholic fatty liver disease in mice model
por: Bae, Jaehyun, et al.
Publicado: (2022)

Impaired ketogenesis is associated with metabolic-associated fatty liver disease in subjects with type 2 diabetes
por: Lee, Sejeong, et al.
Publicado: (2023)

Low-dose pioglitazone can ameliorate learning and memory impairment in a mouse model of dementia by increasing LRP1 expression in the hippocampus
por: Seok, Hannah, et al.
Publicado: (2019)

Predictors of the Therapeutic Efficacy and Consideration of the Best Combination Therapy of Sodium-Glucose Co-transporter 2 Inhibitors
por: Lee, Ji-Yeon, et al.
Publicado: (2019)

Ipragliflozin, an SGLT2 Inhibitor, Ameliorates High-Fat Diet-Induced Metabolic Changes by Upregulating Energy Expenditure through Activation of the AMPK/ SIRT1 Pathway
por: Lee, Ji-Yeon, et al.
Publicado: (2021)

Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study)
por: Cho, Yongin, et al.
Publicado: (2022)

The Effectiveness of Intermittent Fasting to Reduce Body Mass Index and Glucose Metabolism: A Systematic Review and Meta-Analysis
por: Cho, Yongin, et al.
Publicado: (2019)

Myocardial atrophy in children with mitochondrial disease and Duchenne muscular dystrophy
por: Lee, Tae Ho, et al.
Publicado: (2014)

Survival analysis of spinal muscular atrophy type I
por: Park, Hyun Bin, et al.
Publicado: (2010)

Pre-sarcopenia is associated with renal hyperfiltration independent of obesity or insulin resistance: Nationwide Surveys (KNHANES 2008–2011)
por: Han, Eugene, et al.
Publicado: (2017)

Proteinuria Is Associated with Carotid Artery Atherosclerosis in Non-Albuminuric Type 2 Diabetes: A Cross-Sectional Study
por: Bae, Jaehyun, et al.
Publicado: (2020)

Ipragliflozin Additively Ameliorates Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Controlled with Metformin and Pioglitazone: A 24-Week Randomized Controlled Trial
por: Han, Eugene, et al.
Publicado: (2020)

Anatomic fat depots and cardiovascular risk: a focus on the leg fat using nationwide surveys (KNHANES 2008–2011)
por: Han, Eugene, et al.
Publicado: (2017)

Epidural anesthesia for the patient with type IV spinal muscular atrophy -A case report-
por: Kim, Seon Jin, et al.
Publicado: (2010)

The Relationship between Increases in Morning Spot Urinary Glucose Excretion and Decreases in HbA(1C) in Patients with Type 2 Diabetes After Taking an SGLT2 Inhibitor: A Retrospective, Longitudinal Study
por: Kim, So Ra, et al.
Publicado: (2017)

Glycemic Effects of Once-a-Day Rapid-Acting Insulin Analogue Addition on a Basal Insulin Analogue in Korean Subjects with Poorly Controlled Type 2 Diabetes Mellitus
por: Choe, Eun Yeong, et al.
Publicado: (2012)

The Use of Korean Medicine to Treat Patients with Spinobulbar Muscular Atrophy, Kennedy’s Disease - A Case Study
por: Lee, Seongjin, et al.
Publicado: (2017)

Characteristics Predictive for a Successful Switch from Insulin Analogue Therapy to Oral Hypoglycemic Agents in Patients with Type 2 Diabetes
por: Kim, Gyuri, et al.
Publicado: (2016)

Differential Effects of Thiazolidinediones and Dipeptidyl Peptidase-4 Inhibitors on Insulin Resistance and β-Cell Function in Type 2 Diabetes Mellitus: A Propensity Score-Matched Analysis
por: Bae, Jaehyun, et al.
Publicado: (2018)

Comparison of Renal Effects of Ezetimibe–Statin Combination versus Statin Monotherapy: A Propensity-Score-Matched Analysis
por: Bae, Jaehyun, et al.
Publicado: (2020)

Metformin Restores Parkin-Mediated Mitophagy, Suppressed by Cytosolic p53
por: Song, Young Mi, et al.
Publicado: (2016)

The renal tubular damage marker urinary N-acetyl-β-d-glucosaminidase may be more closely associated with early detection of atherosclerosis than the glomerular damage marker albuminuria in patients with type 2 diabetes
por: Kim, So Ra, et al.
Publicado: (2017)

Diabetes self-assessment score and the development of diabetes: A 10-year prospective study
por: Kim, Gyuri, et al.
Publicado: (2017)

Morning Spot Urine Glucose-to-Creatinine Ratios Predict Overnight Urinary Glucose Excretion in Patients With Type 2 Diabetes
por: Kim, So Ra, et al.
Publicado: (2017)

Urinary N-acetyl-β-d-glucosaminidase, an early marker of diabetic kidney disease, might reflect glucose excursion in patients with type 2 diabetes
por: Kim, So Ra, et al.
Publicado: (2016)

Effects of Serum Albumin, Calcium Levels, Cancer Stage and Performance Status on Weight Loss in Parathyroid Hormone-Related Peptide Positive or Negative Patients with Cancer
por: Lee, Ji-Yeon, et al.
Publicado: (2018)

Differential association of ezetimibe-simvastatin combination with major adverse cardiovascular events in patients with or without diabetes: a retrospective propensity score-matched cohort study
por: Lee, Yong-ho, et al.
Publicado: (2018)

Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study
por: Lee, Hyeok-Hee, et al.
Publicado: (2020)

Comparison between Atorvastatin and Rosuvastatin in Renal Function Decline among Patients with Diabetes
por: Han, Eugene, et al.
Publicado: (2017)

The protective effect of delta-aminolevulinic acid dehydratase 1-2 and 2-2 isozymes against blood lead with higher hematologic parameters.
por: Kim, Hee-Seon, et al.
Publicado: (2004)

Serum Cholesterol Concentration and Prevalence, Awareness, Treatment, and Control of High Low‐Density Lipoprotein Cholesterol in the Korea National Health and Nutrition Examination Surveys 2008–2010: Beyond the Tip of the Iceberg
por: Lee, Yong‐ho, et al.
Publicado: (2014)

Genotype-Phenotype Correlation of SMN1 and NAIP Deletions in Korean Patients with Spinal Muscular Atrophy
por: Ahn, Eun-Ji, et al.
Publicado: (2017)

Spinal muscular atrophy-like phenotype in a mouse model of acid ceramidase deficiency
por: Nagree, Murtaza S., et al.
Publicado: (2023)

Association Between Serum Bilirubin and the Progression of Carotid Atherosclerosis in Type 2 Diabetes
por: Lee, Inkuk, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2oocta143qeh59e4kkn1milq2t